Skip to main content
Equibles
PODD logo

PODD · Insulet Corp · Metrics

Track PODD — free

Use PODD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PODD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$140.60 -0.95 (-0.67%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$9.48B
Shares
69.35M

PODD metrics

87 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$141.55
Market cap
$9.48B

Price action

20 metrics
Price change (1W)
+5.1%
Price change (30D)
-6.6%
Price change (3M)
-2.9%
Price change (6M)
-38.1%
Price change (YTD)
-50.2%
Price change (1Y)
-56.1%
Trailing year
Price change (5Y)
-51.6%
52-week high
$346.36
52-week low
$131.96
Change from 52-week high
-59.1%
Change from 52-week low
+7.3%
Annualized volatility
44.8%
Annualized volatility (3M)
55.8%
Beta
0.3
RSI (14D)
46.3
Price vs SMA 50
-6.3%
Price vs SMA 200
-30.1%
Avg volume (3M)
1.67M
Relative volume
0.7
Average dollar volume
$249.76M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
69.35M

Valuation

12 metrics
P / E (TTM)
26.6
Trailing earnings · reciprocal yield 3.8%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.1×
reciprocal yield 32.2%
P / book
6.7
reciprocal yield 15.0%
FCF yield
3.1%
TTM · current market cap
Buyback yield
3.5%
P / FCF
32.3
reciprocal yield 3.1%
P / operating cash flow
18.5
reciprocal yield 5.4%
Earnings yield
4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
74.4×
reciprocal yield 1.3%
P / E historical average (5Y)
2,168.9×
reciprocal yield 0.0%
EV / revenue historical average (3Y)
7.9×
reciprocal yield 12.6%
EV / revenue historical average (5Y)
11.7×
reciprocal yield 8.6%
EV / EBIT historical average (3Y)
63.4×
reciprocal yield 1.6%
EV / EBIT historical average (5Y)
175.9×
reciprocal yield 0.6%
EV / EBITDA historical average (3Y)
46.9×
reciprocal yield 2.1%
EV / EBITDA historical average (5Y)
88.3×
reciprocal yield 1.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
3.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
71.1%
Operating margin
16.9%
Trailing 12 months
Net margin
12.3%
Gross profit (TTM)
$2.17B
Operating profit (TTM)
$515.70M
Net income (TTM)
$375.30M
Trailing 12 months
Diluted EPS (TTM)
$5.33
FCF margin
9.6%
Effective tax rate
24.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$21.53

Growth

11 metrics
Revenue growth YoY
+23.5%
Year over year
Net income growth YoY
+322.2%
Revenue (TTM)
$3.05B
Trailing 12 months
EPS growth YoY
+328.1%
Shares change YoY
-1.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+27.5%
Revenue CAGR (5Y)
+24.5%
EPS CAGR (3Y)
+267.7%
EPS CAGR (5Y)
+103.4%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
26.4%
Return on assets
11.9%
Debt / equity
—
Current ratio
2.5
EBITDA (TTM)
$615.00M
Free cash flow (TTM)
$293.70M
Quick ratio
1.8
Interest coverage
8.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$534.90M
Total assets
$3.17B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$511.20M
Capital expenditures (TTM)
$217.50M
R&D (TTM)
$345.90M
SG&A (TTM)
$1.31B
Stock compensation (TTM)
$77.90M
R&D / revenue
11.3%
Stock compensation / revenue
2.6%

Ownership (13F)

3 metrics
13F filers
729
13F filer change QoQ
-65
Institutional ownership
103.2%

Short interest

3 metrics
Short interest
6.4%
Latest settlement · 2.4 days to cover
Days to cover
2.4d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
$162,217
Insider-sentiment score
77 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1145197 CUSIP 45784P101 13F (30d) 24 filings 22 filers Visit website Investor relations